Trexan Tablet 2.5 mg

Quick links

Choose a section

Quick links to important sections

Advertisements

Trexan Tablet 2.5 mg

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Trexan Tablet 2.5 mg

Quick Facts

Property Description
Active Ingredient Methotrexate
Form Tablet
Pharmacological Class Antimetabolite, Folic Acid Antagonist
General Purpose To reduce immune activity and control cell growth
Origin Synthetic

Trexan Tablet 2.5 mg: Definition and Core Composition

Trexan Tablet 2.5 mg is a synthetic, prescription-only pharmaceutical product presented as a tablet intended for oral administration, containing the single active ingredient, Methotrexate. The 2.5 mg concentration refers to the amount of active Methotrexate equivalent present in the formulation, reflecting a standardized dosage for chronic therapy.

This preparation is defined by the presence of Methotrexate within a solid excipient base. The medicine is primarily classified as an Antimetabolite and is specifically known as a Folic Acid Antagonist within its pharmacological class. The tablet form allows for consistent oral administration, distinguishing it from injectable formulations of the same drug.


Classification and General Purpose

Methotrexate's classification as a Folic Acid Antagonist indicates that the substance is designed to interfere with the body's utilization of folic acid, a critical factor for cell reproduction. Due to its impact on the immune system, it is further categorized as a potent Immunosuppressant and a Disease-Modifying Anti-Rheumatic Drug (DMARD), highlighting its role in controlling long-term inflammatory disease activity.

The general purpose of this medication is to provide control over chronic conditions characterized by two principal mechanisms: excessive inflammation caused by an overactive immune system, and rapid, abnormal cell proliferation. Methotrexate is utilized for suppressing immune cell function and delivering a cytotoxic effect on rapidly dividing tissues. The drug aims to modify the underlying disease process through a strong, systemic anti-inflammatory effect and the interruption of aberrant cell growth.

Advertisements

What side effects are possible with Trexan Tablet 2.5 mg?

Possible Side Effects and Safety Information

The safety profile of Trexan (Methotrexate) is formally documented by regulatory authorities, classifying adverse reactions by frequency and the body system affected. The medicine’s action as a Folic Acid Antagonist means that rapidly dividing cells are primarily impacted, leading to recognized risks in specific organ systems.


Official Adverse Reaction Scope

Adverse effects are categorized using standard frequency terminology:

  • Very Common (Affecting ge 1 in 10): Elevated liver transaminases (liver enzymes).
  • Common (Affecting ge 1 in 100): Leukopenia (reduced white blood cells), thrombocytopenia, nausea, vomiting, stomatitis (mouth inflammation), diarrhea, abdominal pain, rash, and fatigue.

The most frequently observed effects involve the Gastrointestinal System and Blood and Lymphatic System.


Serious Adverse Reactions and Systemic Constraints

The official labeling identifies several serious adverse reactions that affect major organ systems, requiring structured monitoring:

  • Organ Toxicity: Risks include Pulmonary Toxicity (interstitial pneumonitis) and severe Hepatotoxicity (liver damage), which may progress to fibrosis or cirrhosis, particularly when associated with prolonged use and cumulative dose.
  • Myelosuppression: Profound bone marrow depression leading to conditions like pancytopenia is a recognized serious risk.

Population-Specific Safety: Use is generally contraindicated in pregnant women for non-neoplastic conditions due to embryo-fetal toxicity. Caution or dosage adjustment is required in patients with renal or hepatic impairment as drug clearance is affected. Furthermore, the label notes that combining the medicine with certain NSAIDs can lead to unexpectedly severe toxicity.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Documented Overdose Manifestations and Actions

The official regulatory documentation states that an overdose of Methotrexate (the active ingredient in Trexan Tablet 2.5 mg) can lead to severe, potentially fatal toxicity. The most frequently documented clinical signs are related to severe myelosuppression (including leukopenia, thrombocytopenia, and anemia) and gastrointestinal toxicity (such as severe stomatitis and diarrhea). Other severe outcomes include acute renal failure and hepatic failure.

When to Seek Immediate Medical Help

Official prescribing information mandates that patients or caregivers must seek immediate medical attention or contact emergency services immediately upon any suspicion of an overdose or if severe signs of toxicity are observed. Overdose is considered a medical emergency requiring rapid intervention.

Classification Aspect Official Regulatory Statement
Severity Classification Overdosage carries the risk of severe toxicity, potentially leading to fatal outcomes.
Emergency Response A specific antidote, Leucovorin (folinic acid), must be administered as promptly as possible to counteract the toxicity.
Monitoring Management requires close and continuous hospital monitoring of blood counts, liver function, renal function, and serum Methotrexate levels.

Patients with impaired renal function or elderly patients are noted to be at an increased risk of severe toxicity due to delayed drug clearance.

Advertisements

Therapeutic Uses of Trexan Tablet 2.5 mg

What Trexan Tablet 2.5 mg Treats: Main Uses and Benefits

Trexan (Methotrexate) is commonly used to help manage conditions presenting with systemic or localized discomfort and heightened physiological activity. This includes treating severe, active Rheumatoid Arthritis (RA) in adults, Polyarticular Juvenile Idiopathic Arthritis (pJIA) in children, disabling Psoriasis, and certain neoplastic conditions.

The medication is generally used to address symptoms related to inflammatory or irritative states, like significant joint pain and swelling, and symptoms that interfere with daily functioning, like severe skin plaques. In these contexts, Trexan provides support that helps ease the overall symptom burden and assists with maintaining functional stability.

“The key benefit supports the patient during difficult episodes by easing distress and contributes to improved comfort during periods of heightened symptoms.”

The primary therapeutic goal is commonly used to help with addressing conditions where functional stability becomes affected. It may be part of symptomatic management in long-term maintenance contexts following initial intensive treatments.


Quick Fact: Relief for Chronic Inflammatory Symptoms

Trexan is relevant in clinical settings where supportive symptom management is appropriate for conditions characterized by persistent systemic discomfort and functional strain in affected joints and skin.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Trexan Tablet is an approved treatment for selected adult patients with active rheumatoid arthritis and severe, disabling psoriasis or psoriatic arthritis that has not responded adequately to other therapies. It is also used in children and adults for the maintenance phase of Acute Lymphoblastic Leukemia (ALL) and for polyarticular juvenile idiopathic arthritis (pJIA).

Use is strictly contraindicated in certain populations, including:

  • Pregnant women for non-cancer conditions (risk of embryo-fetal toxicity and death).
  • Patients with alcoholism or pre-existing liver disease (hepatotoxicity).
  • Patients with significant blood disorders (pre-existing blood dyscrasias, severe bone marrow suppression).
  • Individuals with known hypersensitivity to methotrexate or an immunodeficiency syndrome.

Restrictions and Special Considerations:

  • Reproductive Potential: Both male and female patients of childbearing potential must use effective contraception during and for a specified time after treatment.
  • Renal/Kidney Impairment: Use requires extreme caution, and dosage adjustment or discontinuation is often necessary for patients with impaired kidney function.
  • Lactation: Use is generally not recommended while breastfeeding.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Trexan Tablet 2.5 mg (Methotrexate) describes clinically significant interactions based on reduced elimination and additive toxicity.

Classification Official Regulatory Information
Interacting Medicines Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Penicillins, Sulfonamides, Proton Pump Inhibitors (PPIs), Probenecid, Trimethoprim, Co-trimoxazole, Leflunomide, and Ciclosporin.
Contraindicated Combinations The co-use of alcohol or the presence of alcoholic liver disease is formally prohibited in non-neoplastic indications (e.g., Rheumatoid Arthritis or Psoriasis).
Exposure Modification Substances like NSAIDs and Penicillins are officially documented to reduce methotrexate's renal clearance, which increases its plasma concentration (exposure). PPIs such as Omeprazole are also reported to inhibit its elimination.
Additive Toxicity Trimethoprim and Co-trimoxazole cause additive antifolate effects, leading to a heightened risk of severe hematologic (bone marrow) suppression. Other hepatotoxic or myelosuppressive medicines similarly increase the risk of organ damage.
Population Note The risk of adverse reactions from reduced elimination is officially noted as greater in patients with pre-existing renal impairment and those with hepatic impairment.

These patterns structure the interaction profile around preventing the accumulation of the drug and avoiding combination with products that share or enhance its toxic effects on the liver and bone marrow. The profile specifies formal restrictions on co-administration with substances that interfere with its primary elimination routes or augment its antifolate activity.

Advertisements

Mechanism of Action

How Trexan Tablet 2.5 mg Works

Trexan (methotrexate) acts by affecting two key biochemical pathways, involving enzyme inhibition and mediator release.


Enzyme Inhibition and Folate Pathway Adjustment

The drug functions as an inhibitor of the enzyme dihydrofolate reductase (DHFR), which is essential for the metabolism of folic acid. This interference blocks the synthesis of DNA/RNA building blocks (purines and pyrimidines). This mechanistic cascade occurs in pathways where rapid cell proliferation is active, such as in lymphocytes. This pathway adjustment results in the inhibition of cell growth and expansion within the affected pathways, thereby modulating immune cell activity.


Anti-Inflammatory Signaling via Adenosine

Trexan also engages mechanisms that promote the extracellular release of adenosine, a naturally occurring anti-inflammatory mediator. Elevated adenosine binds to specific adenosine receptors on the surface of immune cells, initiating signaling sequences that suppress the production of key pro-inflammatory cytokines (chemical messengers). This action reduces the generation of pro-inflammatory cytokines, resulting in altered physiological responses in affected tissues.

Advertisements

Dosage and Administration Information

Official Administration Guidelines: Trexan Tablet 2.5 mg

Trexan Tablet 2.5 mg is formulated for oral administration. The dosage is highly dependent on the condition being addressed, but for non-neoplastic diseases (such as rheumatoid arthritis and psoriasis), a once-weekly frequency is the mandatory principle of administration. Taking the dose daily for these conditions constitutes an administration error that can result in severe outcomes.


Usage Domain Official Instruction Labeled Dosing Regimen
Administration Route Oral, swallowed whole with water. Tablets must not be crushed. All doses for chronic diseases are taken by mouth.
Frequency Rule Strictly once weekly (not daily). The day of intake should be consistent and specified by the prescriber. Intermittent, long-term maintenance pattern.
Adult Dosing Range Rheumatoid Arthritis: Initial dose is typically 7.5 mg once weekly, with adjustments not exceeding 20 mg per week. Psoriasis: Dose ranges from 10 mg to 25 mg once weekly; typically not exceeding 30 mg per week. All doses for these indications follow the weekly schedule.
Pediatric Dosing For Polyarticular Juvenile Idiopathic Arthritis (pJIA), the recommended dose is generally based on body surface area, typically 10 mg/m^2 once weekly.

The dose may be taken as a single amount or in three divided doses, spaced twelve hours apart, administered only on the designated day of the week. Dosage adjustments are required for patients with renal impairment, as elimination is primarily through the kidneys. If a weekly dose is missed, a healthcare professional must be contacted immediately for guidance. The entire course of therapy for chronic inflammatory conditions is a long-term treatment that requires careful dose titration to the lowest possible effective level.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Trexan Tablet 2.5 mg

The following information summarizes the types of clinical studies that have been conducted for Trexan (Methotrexate), what was observed in patient groups, and where the research remains uncertain. Findings describe group patterns, not individual outcomes, and do not determine whether an individual will respond similarly.

Evidence for Use in Rheumatoid Arthritis (RA) in Adults

The evidence landscape for this medication in adult RA primarily includes Randomized Controlled Trials (RCTs), where researchers examined patient groups over defined short-term and intermediate time intervals. These studies explored outcomes related to systemic or functional imbalance, such as swollen and tender joint counts, along with complex disease activity scores. Large observational cohort studies also monitored patients over many years.

Findings described patterns in the measurements observed in standardized indices of disease activity. Research also examined radiographic progression (structural joint damage) by reporting measurements over long-term observation periods. Comparative research is lacking between the oral tablet form and the injectable form regarding differences in final outcomes related to physical discomfort. Subgroup findings are uncertain concerning patients with certain pre-existing conditions.

Evidence for Use in Polyarticular Juvenile Idiopathic Arthritis (pJIA)

Researchers examined the use of this medication in pJIA through placebo-controlled trials and long-term cohort studies specific to children and adolescents. These studies explored outcomes reflecting daily functioning in young people, as well as the achievement of predefined treatment response criteria. Research reported measurements of change in patient-reported measures of well-being and function over the defined time intervals.

The data for certain groups remain insufficient, particularly concerning the full extent to which observed patterns are maintained over many years into adulthood. Additionally, evidence quality varies across studies due to differences in methods and patient groups. Limited insight exists into optimal administration for maximizing patient retention on therapy in young people.

What is Still Uncertain About Trexan Tablet 2.5 mg

Despite being a well-established treatment, the research highlights what is known — and what is still uncertain. Follow-up durations were limited in many RCTs, meaning the durability of the initial results may not be fully known across the entire course of a chronic illness. Data are still emerging regarding optimal use and outcomes in patients with conditions where symptoms may vary in intensity who have certain concurrent health issues.

Key Studies & References

  1. Methotrexate in Moderate to Severe Psoriasis: Review of the Literature and Expert Recommendations
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Trexan Tablet 2.5 mg (FAQ)


Q: Does Trexan Tablet 2.5 mg require any special monitoring or lab tests?

A: Official information indicates that periodic monitoring is required before and throughout treatment. This generally involves checking your blood counts (which includes white blood cells, red blood cells, and platelets) and liver function. Monitoring is performed to help the healthcare provider track the body’s response and check for potential signs of toxicity.


Q: Can Trexan Tablet 2.5 mg affect fertility in men or women?

A: Regulatory documents state that this medicine can cause impaired fertility or temporary sterility in both men and women. For this reason, the official labeling advises that effective contraception is recommended during and for a specific period after treatment.


Q: What happens if I accidentally take two Trexan Tablet 2.5 mg doses close together?

A: Regulatory documents warn that dosage errors, such as taking the medicine too frequently or too much, can lead to severe toxic reactions in the blood, liver, and mouth. Official guidance for any suspected overdose states that immediate emergency medical attention should be sought.


Q: What official warnings are associated with Trexan Tablet 2.5 mg use?

A: Official product information contains boxed warnings regarding several serious risks. These include the potential for severe liver damage (hepatotoxicity), lung inflammation (pulmonary toxicity), and bone marrow suppression (myelosuppression). The warnings also highlight the risk of serious toxic reactions that can occur from incorrect administration, such as taking the drug daily instead of weekly.


Q: What is the risk of infections while taking Trexan Tablet 2.5 mg?

A: Because this medicine works as an immunosuppressant, it can lower the number of white blood cells (leukopenia), which are critical for fighting illness. Official sources state that this may increase the risk of developing serious or potentially fatal infections. Official guidance states that signs of infection, such as fever or a sore throat, should be reported to a healthcare provider immediately.


Q: Does Trexan Tablet 2.5 mg affect the kidneys?

A: The medicine is primarily removed from the body by the kidneys, and its elimination is reduced in patients with kidney problems. Regulatory data indicates that the drug can cause kidney damage (renal insufficiency), and this makes existing toxicity risks higher. The product information indicates that careful monitoring and dose adjustment are required for individuals with kidney impairment.


Q: What information is available about long-term research on Trexan Tablet 2.5 mg?

A: Official clinical data, including long-term studies, indicates that for chronic conditions like rheumatoid arthritis, the treatment is effective in maintaining improvements in disease activity over time. Research also shows that in patient groups, it can slow down radiographic progression (structural joint damage) over years of observation.


Q: Is Trexan Tablet 2.5 mg available in different strengths?

A: While the name specifically references the 2.5 mg strength, the active ingredient, methotrexate, is commonly manufactured and available in various tablet strengths. These include 5 mg, 7.5 mg, 10 mg, and 15 mg, which are used to achieve the prescribed weekly dosage.


Q: What are the signs that Trexan Tablet 2.5 mg might be causing liver issues?

A: Official product information notes that the medicine can cause severe liver injury. Signs that may require urgent medical attention include yellowing of the skin or eyes (jaundice), persistent fatigue, fever, rash, or pain in the upper right side of the abdomen. Liver issues are monitored by healthcare providers using regular lab tests, as described in the safety information.


Q: Why do doctors check my blood count before and during treatment with Trexan Tablet 2.5 mg?

A: Doctors check blood counts to assess the risk of bone marrow depression (myelosuppression), which is a serious, documented risk of the medicine. This condition can lead to dangerously low levels of key blood cells, increasing the risk of both bleeding and severe infection. Regular checks are performed to assess the risk of developing these complications during treatment.


Q: Are there any specific lifestyle changes that help when taking Trexan Tablet 2.5 mg?

A: Official information strictly contraindicates the use of alcohol due to the enhanced risk of liver damage. Additionally, because the medicine suppresses the immune system, patients are officially advised to reduce contact with people who have active infections to minimize the risk of illness.


Q: Is Trexan Tablet 2.5 mg considered a chemotherapy drug?

A: Yes, methotrexate is classified by official medical bodies as an antimetabolite chemotherapy drug due to its core function of interfering with cell growth pathways. Although it is used at much lower doses for chronic inflammatory diseases than for cancer, it retains this technical pharmacological classification.


Q: How long does it typically take for Trexan Tablet 2.5 mg to start working for its main uses?

A: Official guidelines and clinical studies indicate that for chronic inflammatory conditions, the full therapeutic benefit is not immediate. Significant improvements in symptoms and disease activity are often observed after 4 to 12 weeks of taking the medicine at a stable dose.


Q: What kind of specialist usually prescribes Trexan Tablet 2.5 mg?

A: According to official guidelines, the drug must only be used by physicians experienced in antimetabolite therapy. For conditions like rheumatoid arthritis and psoriasis, the medicine is typically prescribed by specialists such as rheumatologists or dermatologists. For cancer, it is prescribed by oncologists.


Q: Is it true that Trexan Tablet 2.5 mg can sometimes cause hair thinning?

A: Yes, regulatory and official sources report hair loss (alopecia) as a possible side effect of methotrexate. While this is noted, the reported incidence of hair loss may vary among individuals, especially between the doses used for cancer and chronic inflammatory conditions.


Q: Why is Trexan Tablet 2.5 mg sometimes given with another medicine called folic acid?

A: Methotrexate is classified as an antifolate, meaning it works by interfering with the body’s use of folic acid. Folic acid or folinic acid is often prescribed alongside it, to be taken on a separate day, specifically to reduce the occurrence of common side effects like mouth sores and general nausea.


Q: Can Trexan Tablet 2.5 mg affect how my skin reacts to the sun?

A: Official labeling for the drug includes warnings that it can cause photosensitivity (increased sensitivity to sunlight). This can result in an exaggerated, severe sunburn-like reaction upon sun exposure. For this reason, official guidance recommends using protective measures, such as high-factor sunscreen and protective clothing, when exposed to sunlight.


Q: Can Trexan Tablet 2.5 mg cause changes in mood or thinking?

A: Official drug labeling documents list central nervous system (CNS) adverse reactions such as headache, fatigue, and drowsiness. While direct mood disorders are not typically listed, these central nervous system (CNS) effects are described in the product information.


Q: Are there any known interactions between Trexan Tablet 2.5 mg and over-the-counter cold medicines?

A: Yes, some over-the-counter cold medicines may contain ingredients that interact with Trexan. For instance, NSAIDs (like ibuprofen) can increase the drug’s toxicity, and certain antibiotics containing trimethoprim can enhance its antifolate effects. Official guidance suggests that all non-prescription medicines should be reviewed by a doctor or pharmacist.


Q: Are there any specific dietary restrictions when using Trexan Tablet 2.5 mg?

A: The only formal dietary restriction is the strict prohibition of alcohol due to the increased risk of liver damage. Some medical sources mention the potential risk of infection and advise caution regarding unpasteurized foods. Limiting high caffeine intake has also been explored due to potential interference with the medicine.


Q: Does Trexan Tablet 2.5 mg interact with vaccines or injections?

A: Yes, official safety information states that due to the drug's immunosuppressant effects, live vaccines (which use a weakened form of the virus) are contraindicated as they carry the risk of causing a severe infection. Official guidance states that patients should consult with their doctor regarding any planned vaccinations.


Q: Do older adults (seniors) need a different approach when taking Trexan Tablet 2.5 mg?

A: Official regulatory documents note that the risk of toxicity from the medicine is greater in patients with pre-existing kidney impairment. Since this condition is more common in older adults, the official guidance necessitates careful dose monitoring and potentially dosage adjustment in this population.


Q: Why do some people stop using Trexan Tablet 2.5 mg?

A: Research studies and regulatory data show that patients may stop treatment for several reasons. The main reasons are often due to intolerable side effects (adverse reactions) or if the medicine is not effectively controlling their disease activity (lack of efficacy).


Q: Does Trexan Tablet 2.5 mg interact with herbal supplements?

A: Official labeling advises caution with all concurrent medicines. Some herbal supplements, such as St. John’s wort, are documented to potentially increase risks like photosensitivity or interfere with how the body processes the drug. Official guidance states that patients should discuss all herbal supplements with their healthcare professional.

Advertisements

How should Trexan Tablet 2.5 mg be stored and disposed of?

How to Store and Dispose of Trexan Tablet 2.5 mg

Trexan (methotrexate) tablets must be stored according to strict regulatory conditions to ensure stability and safety, particularly due to its classification as a cytotoxic drug.

Official Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F), protected from excessive heat.
Protection Must be protected from light and kept in a well-closed, light-resistant container.
Child Safety Keep out of the reach of children and pets in a secure location, as accidental ingestion can be lethal. The container must have a child-resistant closure.

Handling and Disposal

As a cytotoxic agent, the medication requires adherence to special handling and disposal procedures as mandated by local regulations. Unused or expired Trexan should not be thrown in household trash or flushed down the toilet. Instead, it must be disposed of by returning it to a drug take-back program or a regulated pharmaceutical waste collection point.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Trexan Tablet 2.5 mg found in:

A-Z Index: